BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 3433253)

  • 21. [Current biological surveillance of oral anticoagulant treatment].
    Helft G; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
    McGlasson DL
    Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.
    Sermon AM; Smith JM; Maclean R; Kitchen S
    Thromb Haemost; 2010 Apr; 103(4):757-65. PubMed ID: 20174759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The international normalization ratio in the monitoring of oral anticoagulant therapy].
    Sansores-García L; Majluf-Cruz AS; Vargas-Vorácková F; Labardini-Méndez J
    Rev Invest Clin; 1993; 45(5):463-7. PubMed ID: 8134728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simplified procedure for thromboplastin calibration--the usefulness of lyophilized plasmas assessed in a collaborative study.
    Tripodi A; Chantarangkul V; Manotti C; Poggi M; Braga M; Akkawat B; Bucciarelli P; Mannucci PM
    Thromb Haemost; 1996 Feb; 75(2):309-12. PubMed ID: 8815582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
    Guglielmone HA; Vides MA
    Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of oral anticoagulant therapy.
    Biemer JJ
    Ann Clin Lab Sci; 1988; 18(6):421-8. PubMed ID: 3239946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prothrombin time and its standardization].
    Kagawa K
    Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality control and oral anticoagulation.
    Preston FE
    Thromb Haemost; 1995 Jul; 74(1):515-20. PubMed ID: 8578516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombin time standardization: report of the expert panel on oral anticoagulant control. The International Committee on Thrombosis and Haemostasis, The International Committee for Standardization in Hematology.
    Thromb Haemost; 1979 Dec; 42(4):1073-114. PubMed ID: 542923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Present status of standardization in coagulation assays for control of oral anticoagulation.
    Dati F; Becker U
    Behring Inst Mitt; 1988 Apr; (82):309-24. PubMed ID: 3408455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardization of the INR: how good is your laboratory's INR and can it be improved?
    Favaloro EJ; Adcock DM
    Semin Thromb Hemost; 2008 Oct; 34(7):593-603. PubMed ID: 19085760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISI/INR system in Japan: experience from simultaneous measurement of the same plasma at four different laboratories.
    Uetsuka Y; Sakuragawa N; Wada H; Aizawa Y; Aosaki M
    Semin Thromb Hemost; 2000; 26(1):109-12. PubMed ID: 10805291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of concentration of trisodium citrate anticoagulant on calculation of the International Normalised Ratio and the International Sensitivity Index of thromboplastin.
    Duncan EM; Casey CR; Duncan BM; Lloyd JV
    Thromb Haemost; 1994 Jul; 72(1):84-8. PubMed ID: 7974381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of thromboplastins using the ISI and INR system.
    Moriarty HT; Lam-Po-Tang PR; Anastas N
    Pathology; 1990 Apr; 22(2):71-6. PubMed ID: 2235100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin.
    Becker DM; Humphries JE; Walker FB; DeMong LK; Bopp JS; Acker MN
    Arch Pathol Lab Med; 1993 Jun; 117(6):602-5. PubMed ID: 8503731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.